Home Page ::: Current Cancer Drug Targets

ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 15, 9 Issues, 2015


Download PDF Flyer




Current Cancer Drug Targets

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 67th of 202 in

    Oncology


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Ruiwen Zhang


Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.582
5 - Year: 3.859

Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Forthcoming Special Issue(s)

PERSONALIZED THERAPEUTIC APPROACH IN CANCER


Guest Editor(s): Angela Celetti
Tentative Publication Date: November, 2015
Submit Abstract via Email Download Description
Authors' Comments
In terms of “Current Cancer Drug Targets”, the editor-in-chief and the senior manager have done high quality professional job for this journal. I am happy to work with them.
Thank you very much, Best regards.

Dr. Erxi Wu
Has contributed: Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

Current Cancer Drug Targets

,

Volume 15

-

Number 4



Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives

; Pp: 314 - 326

Yasuhide Kitagawa, Satoru Ueno, Hiroyuki Konaka, Atsushi Mizokami, Shiro Hinotsu, Hideyuki Akaza and Mikio Namiki


DOI: 10.2174/156800961504150518112720
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy

; Pp: 327 - 336

Nick Ka Ming Yau, Andrew Yuon Fong, Hiu Fung Leung, Krista Roberta Verhoeft, Qin Ying Lim, Wai Yip Lam, Ian Chi Kei Wong and Vivian Wai Yan Lui


DOI: 10.2174/1568009615666150225123712
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging

; Pp: 337 - 351

Weiqin Wang, Sarra Abbad, Zhenhai Zhang, Shu Wang, Jianping Zhou and Huixia Lv


DOI: 10.2174/1568009615666150211104524
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer


Ryan Stuchbery, NatalieJ. Kurganovs, PatrickJ. McCoy, Colleen C. Nelson, VanessaM. Hayes, Niall M. Corcoran and ChristopherM. Hovens


View Abstract Purchase Online

  
  


MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells


Yan Chen, Fan Feng, Xudong Gao, Chunping Wang, Huiwei Sun, Cuihong Zhang, Zhen Zeng, Yinying Lu, Linjing An, Jianhui Qu, Fusheng Wang and Yongping Yang


View Abstract Purchase Online

  
  


Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo


Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu


View Abstract Download Free

  
  


Heparanase as a Target in Cancer Therapy


Valentina Masola, Maria Francesca Secchi, Giovanni Gambaro and Maurizio Onisto


View Abstract Purchase Online

  
  


Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer


Jiang Ren, Chuanjiang Yu, Shifei Wu, Feng Peng, Qianqian Jiang, Xuechao Zhang, Guoxing Zhong, Huashan Shi, Xiang Chen, Xiaolan Su, Xinmei Luo, Wen Zhu and Yuquan Wei


View Abstract Purchase Online

  
  


Cetuximab Inhibits Gastric Cancer Growth in vivo, Independent of KRAS Status


Min Shi, Hailong Shi, Jun Ji, Qu Cai, Xuehua Chen, Yingyan Yu, Bingya Liu, Zhenggang Zhu and Jun Zhang


View Abstract Purchase Online

  
  


Therapeutic Perspectives on Pancreatic Cancer


Anjali V. Sheahan, Phoebe A. Phillips and Levon M. Khachigian


View Abstract Purchase Online

  
  


Current and Potential Treatments for Cervical Cancer


Grace P.C. Yee, Paul de Souza and Levon M. Khachigian


View Abstract Purchase Online

  
  


The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas


Hailin Tang, Yanhui Bian, Chaofeng Tu, Zeyou Wang, Zhibin Yu, Qing Liu, Gang Xu, Minghua Wu and Guiyuan Li


View Abstract Purchase Online

  
  


Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas


Marc Giry-Laterriere, Andreia V. Pinho, Nils Eling, Lorraine Chantrill and Ilse Rooman


View Abstract

  
  


The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments


Paolo G. Gobbi, Sandro Rossi, Mario Comelli, Valentina Ravetta, Laura L. Rosa, Silvia Brugnatelli, Franco Corbella, Sara Delfanti, Islam Abumalouh and Paolo Dionigi


View Abstract

  
  


CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription


Zanxian Xia, Mingquan Guo, Han Liu, Luwei Jiang, Qiaoxia Li, Jian Peng, Jia-Da Li, Baoen Shan, Pinghui Feng and Hong Ma


View Abstract

  
  


11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition


Vladimir A. D'yakonov, Lilya U. Dzhemileva, Aleksey A. Makarov, Alfiya R. Mulukova, Dmitry S. Baev, Elza K. Khusnutdinova, Tatiana G. Tolstikova and Usein M. Dzhemilev


View Abstract

  
  


An integrative analysis of the putative gefitinib-resistance related genes in a lung cancer cell line model system


Xiaohong Han, Manjiao Liu, Shuai Wang, Guanting Lv, Li Ma, Changqing Zeng and Yuankai Shi


View Abstract

  
  


A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization


Jinlu Ma, Dan Zhang, Xia Ying, Ying Zhao, Chenchen He, Mengjiao Cai, Congya Zhou, Suxia Han and Qing Zhu


View Abstract

  
  


Nanoradiopharmaceuticals for Bone Cancer Metastasis Imaging


Bianca Feliciano Coelho, Marta de Souza Albernaz, Alexandre Iscaife, Kátia Ramos Moreira Leite, Mara de Souza Junqueira, Emerson Soares Bernardes, Emerson Oliveira da Silva and Ralph Santos-Oliveira


View Abstract

  
  


A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy

, 2015; 15(4): 327 - 336

Nick Ka Ming Yau, Andrew Yuon Fong, Hiu Fung Leung, Krista Roberta Verhoeft, Qin Ying Lim, Wai Yip Lam, Ian Chi Kei Wong and Vivian Wai Yan Lui


DOI: 10.2174/1568009615666150225123712
View Abstract Purchase Online Rights and Permissions

  
  


Potential Anti-cancer Drugs Commonly Used for Other Indications

, 2015; 15(1): 35 - 52

Veronika Hanusova, Lenka Skalova, Vera Kralova and Petra Matouskova


DOI: 10.2174/1568009615666141229152812
View Abstract Download Free Rights and Permissions

  
  


Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines

, 2014; 14(9): 832 - 849

Sara Horta, Ana L. Agostinho, Rita Mateus, Lucilia Pereira, Carolina Pereira, Liliana Capinha, Slavomira Doktorovova, Alexandra Brito and Mafalda Videira


DOI: 10.2174/1568009614666141111154713
View Abstract Purchase Online Rights and Permissions

  
  


The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer

, 2014; 14(5): 446 - 457

Wanxing Duan, Jiguang Ma, Qingyong Ma, Qinhong Xu, Jianjun Lei, Liang Han, Xuqi Li, Zheng Wang, Zheng Wu, Shifang Lv, Zhenhua Ma, Mouzhu Liu, Fengfei Wang and Erxi Wu


DOI: 10.2174/1568009614666140402105101
View Abstract Purchase Online Rights and Permissions

  
  


Metabolic Features of Melanoma: A Gold Mine of New Therapeutic Targets?

, 2014; 14(4): 357 - 370

Philippe Marchetti, Pierre Guerreschi, Jerome Kluza and Laurent Mortier


DOI: 10.2174/1568009614666140407113124
View Abstract Purchase Online Rights and Permissions

  
  


Advertisement

Related Journals




Related eBooks




Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science